| 31 Dec 2023 |
MNPR
Monopar Therapeutics Inc
|
Christopher M Starr
Director
|
Option
|
2,533 |
$0.34 |
$862
31 Dec 2023
|
25,863 |
↗
|
| 30 Sep 2023 |
MNPR
Monopar Therapeutics Inc
|
Christopher M Starr
Director
|
Option
|
2,533 |
$0.62 |
$1,570
30 Sep 2023
|
23,330 |
↗
|
| 30 Jun 2023 |
MNPR
Monopar Therapeutics Inc
|
Christopher M Starr
Director
|
Option
|
2,534 |
$0.86 |
$2,167
30 Jun 2023
|
20,797 |
↗
|
| 31 Mar 2023 |
MNPR
Monopar Therapeutics Inc
|
Christopher M Starr
Director
|
Option
|
2,533 |
$1.39 |
$3,521
31 Mar 2023
|
18,263 |
↗
|
| 31 Dec 2022 |
MNPR
Monopar Therapeutics Inc
|
Christopher M Starr
Director
|
Option
|
2,859 |
$2.37 |
$6,776
31 Dec 2022
|
15,730 |
↗
|
| 30 Sep 2022 |
MNPR
Monopar Therapeutics Inc
|
Christopher M Starr
Director
|
Option
|
2,859 |
$1.52 |
$4,346
30 Sep 2022
|
12,871 |
↗
|
| 30 Jun 2022 |
MNPR
Monopar Therapeutics Inc
|
Christopher M Starr
Director
|
Option
|
2,859 |
$2.30 |
$6,575
30 Jun 2022
|
10,012 |
↗
|
| 31 Mar 2022 |
MNPR
Monopar Therapeutics Inc
|
Christopher M Starr
Director
|
Option
|
2,859 |
$2.55 |
$7,290
31 Mar 2022
|
7,153 |
↗
|
| 31 Dec 2021 |
MNPR
Monopar Therapeutics Inc
|
Christopher M Starr
Director
|
Option
|
751 |
$3.21 |
$2,411
31 Dec 2021
|
4,294 |
↗
|
| 30 Sep 2021 |
MNPR
Monopar Therapeutics Inc
|
Christopher M Starr
Director
|
Option
|
751 |
$4.87 |
$3,657
30 Sep 2021
|
3,543 |
↗
|
| 30 Jun 2021 |
MNPR
Monopar Therapeutics Inc
|
Christopher M Starr
Director
|
Option
|
752 |
$5.89 |
$4,429
30 Jun 2021
|
2,792 |
↗
|
| 31 Mar 2021 |
MNPR
Monopar Therapeutics Inc
|
Christopher M Starr
Director
|
Option
|
751 |
$6.20 |
$4,656
31 Mar 2021
|
2,040 |
↗
|
| 30 Sep 2020 |
MNPR
Monopar Therapeutics Inc
|
Christopher M Starr
Director
|
Option
|
644 |
$5.35 |
$3,445
30 Sep 2020
|
1,289 |
↗
|
| 30 Jun 2020 |
MNPR
Monopar Therapeutics Inc
|
Christopher M Starr
Director
|
Option
|
323 |
$7.46 |
$2,410
30 Jun 2020
|
645 |
↗
|
| 31 Mar 2020 |
MNPR
Monopar Therapeutics Inc
|
Christopher M Starr
Director
|
Option
|
322 |
$7.17 |
$2,309
31 Mar 2020
|
322 |
↗
|
| 1 Dec 2005 |
BMRN
Biomarin Pharmaceutical Inc.
|
Christopher M Starr
Sr. VP and Scientific Operations
|
Sale
|
10,571 |
$10.00 |
$105,710
1 Dec 2005
|
295,176 |
↗
|
| 21 Nov 2005 |
BMRN
Biomarin Pharmaceutical Inc.
|
Christopher M Starr
Sr. VP and Scientific Operations
|
Sale
|
10,571 |
$10.00 |
$105,710
21 Nov 2005
|
300,176 |
↗
|
| 3 Jun 2004 |
BMRN
Biomarin Pharmaceutical Inc.
|
Christopher M Starr
Sr. VP and Scientific Operations
|
Sale
|
10,000 |
$7.64 |
$76,400
3 Jun 2004
|
305,176 |
↗
|
| 2 Apr 2004 |
BMRN
Biomarin Pharmaceutical Inc.
|
Christopher M Starr
Sr. VP and Scientific Operations
|
Option
|
5,570 |
$4.00 |
$22,280
2 Apr 2004
|
320,746 |
↗
|
| 1 Apr 2004 |
BMRN
Biomarin Pharmaceutical Inc.
|
Christopher M Starr
Sr. VP and Scientific Operations
|
Sale
|
5,000 |
$7.56 |
$37,800
1 Apr 2004
|
315,176 |
↗
|
| 21 Aug 2003 |
BMRN
Biomarin Pharmaceutical Inc.
|
Christopher M Starr
Sr. VP and Scientific Operations
|
Sale
|
33,000 |
$9.00 |
$297,000
21 Aug 2003
|
320,176 |
↗
|